4.7 Article

mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma

期刊

CELL DEATH & DISEASE
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41419-019-1828-2

关键词

-

资金

  1. National Natural Science Foundation of China [81470875]
  2. Science and Technology Planning Project of Guangdong Province [2015B020229002, 2014B020227002]
  3. Natural Science Foundation of Guangdong Province [2014A030312013]
  4. Science and Technology Program of Guangzhou [201604020002]

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) can be the last step of nonalcoholic fatty liver disease (NAFLD) evolution, and the main characteristic of NAFLD is alteration in lipid metabolism. However, the mechanisms of abnormal lipid metabolism in NAFLD and HCC progression are yet to be identified. Here, we demonstrate that liver-specific activation of mTORC1 promoted the expression of lipid synthesis genes and lead to the development of spontaneous HCC. Genetic mouse models developed spontaneous HCC along with increased expressions of SREBP1, ACC1 and FASN. In addition, high levels of p-STAT5 were observed in the livers and particularly evident in the tumor area. And the synthesis of p-STAT5 was increased in patients along with the increase in SREBP1 synthesis in clinical samples. Moreover, mTORC1 interacts with and phosphorylates the STAT5 in hepatocytes. In conclusion, our data suggested that mTORC1 upregulates SREBP1 transcription via crosstalk with the STAT5 pathway which contributes to the NAFLD-related HCC pathogenesis. And the inhibitor of SREBP1 and mTOR may help to prevent HCC in clinical NAFLD patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell & Tissue Engineering

Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions

Xiao Yi, Feng Chen, Fenghua Liu, Qing Peng, Yang Li, Shao Li, Jiang Du, Yi Gao, Yifeng Wang

STEM CELL RESEARCH & THERAPY (2020)

Article Cell & Tissue Engineering

Robust expansion and functional maturation of human hepatoblasts by chemical strategy

Tingcai Pan, Jiawang Tao, Yan Chen, Jiaye Zhang, Anteneh Getachew, Yuanqi Zhuang, Ning Wang, Yingying Xu, Shenglin Tan, Ji Fang, Fan Yang, Xianhua Lin, Kai You, Yi Gao, Yin-xiong Li

Summary: This study systematically evaluated chemical compounds for the expansion and maturation of hepatoblasts, establishing an effective and cost-efficient method for generating functional human hepatic cells with potential for cell-based therapy and drug discovery applications.

STEM CELL RESEARCH & THERAPY (2021)

Article Chemistry, Multidisciplinary

Reconstructable Uterus-Derived Materials for Uterus Recovery toward Efficient Live Births

Xiao Yi, Fan Liu, Kunjie Gao, Feng Chen, Yifeng Wang, Huayan Li, Xuefeng Wang, Yi Huang, Huijiao Fu, Weijie Zhou, Jun-Bing Fan, Shutao Wang, Yi Gao

Summary: Uterine factor infertility is a growing issue in modern society, but current biomaterial scaffold-mediated systems have limited effectiveness in uterus recovery. This study demonstrates the successful use of reconstructable uterus-derived materials (RUMs), combining uterus-derived extracellular matrix and seeded chorionic villi mesenchymal stem cells, to achieve efficient live births in rats with severe uterine injury. This research provides a potential regenerative medicine therapy for uterine factor infertility.

ADVANCED MATERIALS (2022)

Article Gastroenterology & Hepatology

A strategy of vascular-targeted therapy for liver fibrosis

Yuan Lin, Meng-Qi Dong, Zhi-Min Liu, Meng Xu, Zhi-Hao Huang, Hong-Juan Liu, Yi Gao, Wei-Jie Zhou

Summary: There are currently no effective treatments for liver fibrosis, a disease that involves angiogenesis. The role of different microvessels in the liver during fibrogenesis is unclear, and it is difficult to treat liver fibrosis through vascular targeting. This study proposes a combined regulation of multiple different endothelial cell regulatory signaling pathways as a new strategy for liver fibrosis therapy.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma

Sze Keong Tey, Samuel Wan Ki Wong, Janice Yuen Tung Chan, Xiaowen Mao, Tung Him Ng, Cherlie Lot Sum Yeung, Zoe Leung, Hui Ling Fung, Alexander Hin Ning Tang, Danny Ka Ho Wong, Lung-Yi Mak, Man-Fung Yuen, Chun-Fung Sin, Irene Oi-Lin Ng, Stephanie Kwai Yee Ma, Terence Kin Wah Lee, Peihua Cao, Kebo Zhong, Yi Gao, Jing Ping Yun, Judy Wai Ping Yam

Summary: This study uncovered the crucial role of EV-pIgR in regulating cancer stemness and aggressiveness, with the blockade of EV-pIgR presenting a potential therapeutic strategy for cancer patients.

JOURNAL OF HEPATOLOGY (2022)

Article Immunology

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer

Mingjia Xiao, Xiangjing Liang, Zhengming Yan, Jingyang Chen, Yaru Zhu, Yuan Xie, Yang Li, Xinming Li, Qingxiang Gao, Feiling Feng, Gongbo Fu, Yi Gao

Summary: This study evaluated the role of DNA methylation driven genes in pancreatic cancer and established a four-gene prognostic signature. The signature was found to be associated with tumor histologic grades and survival outcomes, as well as immune dysregulation and tumor mutation burdens. Additionally, the study identified elevated protein expression of these genes in cancerous tissues, which may serve as prognostic markers for pancreatic cancer patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction

Wei-Jian Huang, Xu Zhou, Gong-Bo Fu, Min Ding, Hong-Ping Wu, Min Zeng, Hong-Dan Zhang, Ling-Yan Xu, Yi Gao, Hong-Yang Wang, He-Xin Yan

Summary: This study demonstrated that the administration of soluble molecules can induce endogenous liver progenitor cells, providing an alternative approach for resolving liver fibrosis. Transplanting hepatocyte-derived liver progenitor-like cells alleviated liver fibrosis in mice, while HACY induced the conversion of mature hepatocytes to CD24(+) progenitor cells and inhibited HSC activation, leading to enhanced improvement in liver fibrosis. Comparing to CD24(+) cells induced by CCL4 alone, HACY-induced CD24(+) cells showed enhanced hepatic function and could promote liver function restoration, similar to HepLPCs.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs

Jun Weng, Xu Han, Fanhong Zeng, Yue Zhang, Lei Feng, Lei Cai, Kangyan Liang, Shusong Liu, Shao Li, Gongbo Fu, Min Zeng, Yi Gao

Summary: The study utilized a fiber scaffold bioreactor for high-density, 3D culture of porcine hepatocytes to construct a bioartificial liver and evaluated its protective effects in an ALF porcine model. The bioartificial liver treatment enhanced liver regeneration, alleviated systemic inflammatory response, and reduced extrahepatic organ injury, leading to prolonged survival in the ALF model.

THERANOSTICS (2021)

暂无数据